I think we will run before Ph3. A lot depends on t

I think we will run before Ph3. A lot depends on this upcoming trial and if it is announced and what product it is. Also I suspect this ANDA pending will open some eyes. Not going to get into all my speculation but there are some things I have been thinking about and how the FDA is moving forward and how those items may meet.

There are quite a few catalysts that can jumpstart this thing in a hurry. Someone posted recently how, if it goes from .10 to .20, there is not too much stopping it from going to .50 in this environment. I believe that is correct. Similar to what MJNA recently did.

You really do have an amazing collision of positives coming soon. How they play out and the timing will be key.